adenine and digoxin

adenine has been researched along with digoxin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Bai, H; Shi, L; Wang, XY; Yang, YX; Zhang, XC; Zhang, XH; Zhou, SF; Zhou, ZW1

Other Studies

4 other study(ies) available for adenine and digoxin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
The combination of digoxin and GSK2606414 exerts synergistic anticancer activity against leukemia in vitro and in vivo.
    BioFactors (Oxford, England), 2017, Volume: 43, Issue:6

    Topics: Adenine; Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Digoxin; Drug Combinations; Drug Synergism; Female; G2 Phase Cell Cycle Checkpoints; Humans; Indoles; K562 Cells; Leukemia, Erythroblastic, Acute; Mice; Mice, Nude; Proto-Oncogene Proteins c-akt; THP-1 Cells; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2017